VAERS data released Friday by the CDC included a total of 778,685 reports of adverse events from all age groups following COVID vaccines, including 16,310 deaths and 111,921 serious injuries between Dec. 14, 2020 and Oct. 1, 2021.
Data released Friday by the Centers for Disease Control and Prevention (CDC) showed that between Dec. 14, 2020 and Oct. 1, 2021, a total of 778,685 adverse events following COVID vaccines were reported to the Vaccine Adverse Event Reporting System (VAERS). The data included a total of 16,310 reports of deaths — an increase of 373 over the previous week.
There were 111,921 reports of serious injuries, including deaths, during the same time period — up 6,163 compared with the previous week.
Of the 7,437 U.S. deaths reported as of Oct. 1, 11% occurred within 24 hours of vaccination, 16% occurred within 48 hours of vaccination and 29% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 393.4 million COVID vaccine doses had been administered as of Oct. 1. This includes: 227 million doses of Pfizer, 152 million doses of Moderna and 15 million doses of Johnson & Johnson (J&J).
The data come directly from reports submitted to VAERS, the primary government-funded system for reporting adverse vaccine reactions in the U.S.
Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
This week’s U.S. data for 12- to 17-year-olds show:
- 21,298 total adverse events, including 1,284 rated as serious and 22 reported deaths. Two of the 22 deaths were suicides.
The most recent death involves a 16-year-old male (VAERS I.D. 1734141) who reportedly died from cardiac failure five days after receiving Pfizer’s COVID vaccine.
Other recent deaths include a 17-year-old male (VAERS I.D. 1689212) with cancer who was vaccinated April 17, tested positive for COVID on July 20, was hospitalized and passed away Aug. 29; and a 16-year-old female (VAERS I.D. 1694568) who died from a pulmonary embolism nine days after receiving her first Pfizer dose.
- 3,202 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases
attributed to Pfizer’s vaccine.
- 520 reports of myocarditis and pericarditis (heart inflammation) with 508 cases attributed to Pfizer’s vaccine.
- 114 reports of blood clotting disorders, with all cases attributed to Pfizer.